Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ADD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111233795A details a novel organocatalytic route to chiral gamma-butyrolactones with high stereoselectivity, offering cost-effective API intermediate manufacturing solutions.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and costs for API manufacturing with mild conditions.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of key heterocyclic building blocks.
Patent CN113735778B reveals efficient silver oxide promoted route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113735778A reveals a scalable silver-promoted cyclization for high-purity trifluoromethyl imidazoles, offering significant cost reduction in API manufacturing.
Patent CN113735778B reveals efficient silver oxide promoted route. Delivers high purity imidazole compounds with substantial cost reduction and supply chain reliability for global buyers.
Patent CN112645958A reveals a novel [3+2] cycloaddition route for chiral spiro pyrazolones, offering high diastereoselectivity and simplified supply chain logistics.
Patent CN118126005B reveals metal-free synthesis for fluorinated heterocycles. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier capabilities.
Novel Mo/Cu co-catalyzed method for high-purity triazole synthesis. Reduces cost and improves scalability for pharmaceutical manufacturing.
Patent CN108558882B reveals a novel [3+2] cycloaddition route for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel silver oxide promoted method ensures high purity and scalable production for pharmaceutical intermediates reducing supply chain risks significantly for global buyers seeking reliable partners.
Patent CN113307778A reveals a mild Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering reliable pharmaceutical intermediate supply and cost reduction.
Patent CN111253293B reveals efficient iron-catalyzed synthesis. Delivers high-purity intermediates with significant cost reduction in pharmaceutical manufacturing.
Novel silver oxide promoted method for 5-trifluoromethyl imidazole. High purity, scalable process for pharmaceutical intermediates manufacturing.
Patent CN116253692A reveals a mild, metal-free route to trifluoromethyl-1,2,4-triazines. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity heterocycles.
Patent CN104788370B enables configuration-controlled synthesis of chiral intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.